MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Malignant melanoma and immunotherapy.
Active immunotherapy in malignant melanoma.
Immunotherapy for malignant melanoma: a review and update.
Letter: Ascites in malignant melanoma after oral BCG immunotherapy.
Intralesional immunotherapy for melanoma.
Monocytopoiesis in malignant melanoma: untreated, during immunotherapy and chemoimmunotherapy.
Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
Intratumoral immunotherapy for melanoma.
Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
Progress of immunotherapy in the treatment of malignant melanoma.
Immunotherapy for malignant glioma.
[Sialyltransferase in human malignant melanoma].
Active-specific immunotherapy for melanoma.
Specific active immunotherapy for melanoma.
Combination immunotherapy breakthrough for melanoma.
Advances in immunotherapy for melanoma.
Melanoma immunotherapy.
Cellular immunotherapy for malignant gliomas.
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report.
Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study.
Vitiligo-like depigmentation and morpheas after specific intralymphatic immunotherapy for malignant melanoma.
Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.
Human cutaneous malignant melanoma as a model for cancer.
Melatonin therapy of advanced human malignant melanoma.
Immunotherapy for human malignant melanoma.
The status of immunotherapy up to 1972 for malignant melanoma in man is reviewed. The immunotherapeutic approaches used are based on the demonstration...
806KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Malignant melanoma and immunotherapy.
Active immunotherapy in malignant melanoma.
Immunotherapy for malignant melanoma: a review and update.
Letter: Ascites in malignant melanoma after oral BCG immunotherapy.
Intralesional immunotherapy for melanoma.
Monocytopoiesis in malignant melanoma: untreated, during immunotherapy and chemoimmunotherapy.
Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole.
Intratumoral immunotherapy for melanoma.
Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
Progress of immunotherapy in the treatment of malignant melanoma.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
